SCHEMBL24490646

SCHEMBL24490646

COCc1c(-c2noc(C3CC3)c2C(=O)OC)c2c(NCc3ccc(OC)cc3OC)ncnc2n1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 11/20 0.40
▸ CYP3A4 P08684 11/20 0.40
▸ CYP2C19 P33261 11/20 0.40
▸ CYP2D6 P10635 9/20 0.39
▸ CLK4 Q9HAZ1 8/20 0.39
▸ ALDH1A1 P00352 8/20 0.39
▸ MAPK1 P28482 6/20 0.39
▸ LMNA P02545 5/20 0.39
▸ USP2 O75604 5/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ MAPT P10636 2/20 0.36
▸ HSD17B10 Q99714 6/20 0.35
▸ TSHR P16473 6/20 0.35
▸ CYP2C9 P11712 5/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ RET P07949 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24345334 0.94 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21801374 0.93 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21801377 0.92 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL24345188 0.89 MAPT (0.43) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21801365 0.88 MAPT (0.41) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL28650199 0.88 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21801581 0.88 MAPT (0.40) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21801583 0.84 MAPT (0.40) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL28655516 0.84 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL29681666 0.79 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849986-B1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2022-06-08 — — EP disclosed
Send feedback